Frequency Therapeutics, Inc. (FREQ)

NASDAQ: FREQ · IEX Real-Time Price · USD
2.10
0.00 (0.00%)
Nov 29, 2022 3:48 PM EDT - Market open

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017
Revenue
14.0736.9828.9500
Revenue Growth (YoY)
-61.96%27.77%---
Gross Profit
14.0736.9828.9500
Selling, General & Admin
37.1827.1214.847.064.34
Research & Development
60.9237.4218.7811.8811.97
Other Operating Expenses
001600
Operating Expenses
98.164.5349.6218.9416.31
Operating Income
-84.03-27.55-20.68-18.94-16.31
Interest Expense / Income
0.37-0.99-1.780.110.17
Other Expense / Income
0.27-0.08-0.150.123.76
Pretax Income
-84.67-26.48-18.75-19.17-20.24
Income Tax
0.020.04000
Net Income
-84.69-26.51-18.75-19.17-20.24
Preferred Dividends
001.0500
Net Income Common
-84.69-26.51-19.8-19.17-20.24
Shares Outstanding (Basic)
3432921
Shares Outstanding (Diluted)
3432921
Shares Change
6.50%272.90%465.23%117.69%-
EPS (Basic)
-2.47-0.82-2.29-12.53-28.79
EPS (Diluted)
-2.47-0.82-2.29-12.53-28.79
Free Cash Flow Per Share
-2.30-1.613.83-11.41-23.44
Gross Margin
100.00%100.00%100.00%--
Operating Margin
-597.30%-74.50%-71.40%--
Profit Margin
-602.00%-71.70%-68.40%--
Free Cash Flow Margin
-561.40%-140.20%114.50%--
Effective Tax Rate
-0.02%-0.13%0.00%0.00%0.00%
EBITDA
-80.46-25.89-19.72-18.41-19.53
EBITDA Margin
-572.00%-70.00%-68.10%--
Depreciation & Amortization
3.841.580.810.650.53
EBIT
-84.3-27.47-20.53-19.06-20.06
EBIT Margin
-599.30%-74.30%-70.90%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).